PYXS
Pyxis Oncology Inc
3.20$
-4.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
Pyxis Oncology Inc (PYXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -64 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -2.2 | -10 | -35 | -89 | -71 | -58 | -64 | |
| 0.5 | 0.5 | 0.6 | 0.7 | 1.9 | 3.0 | 4.5 | |
| 0.0 | 0.0 | 6.4 | 16 | 17 | 13 | 12 | |
| 0.0 | 0.0 | 33 | 16 | – | – | – | |
| 0.5 | 2.3 | 6.7 | 4.5 | -12 | -12 | 1.9 | |
| 1.5 | 1.5 | 0.5 | 6.4 | 6.7 | 0.2 | 0.0 | |
| -1.5 | -1.5 | -0.6 | -6.4 | -105 | 8.2 | 59 | |
| – | – | 304 | 0.2 | 0.0 | – | – | |
| 22 | 0.0 | 304 | 0.2 | 5.9 | 59 | 0.6 | |
| 20 | -12 | 268 | -96 | -170 | 9.8 | -4.1 | |
| -2.2 | -12 | -36 | -96 | -77 | -58 | -64 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.